Raymond James raised the firm’s price target on Procter & Gamble to $178 from $175 and keeps an Outperform rating on the shares after fiscal Q3 EPS of $1.52 came in well above the firm’s estimate and consensus. P&G continues to grow profitability ahead of peers even as top-line growth decelerates, notes the firm, which raised its FY24 EPS estimate to $6.56 from $6.44.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble’s Bold Buyback: Balancing Share Repurchases with Financial Health Risks
- PG Earnings: Procter & Gamble’s Q3 Revenues Disappoint
- Procter & Gamble: Uncovering Hidden Gems for Market Growth
- Procter & Gamble expects oil, diesel, pulp costs to impact Q4
- Unusually active option classes on open April 19th